Biogen Overview
Biogen Target Price
Analysts' 12-month price predictions for BIIB.
Share Price
$123.16
Average Target Price
$195.71
58.9% upside
58.9% upside7 analysts in the last 4 months
High: $270 | Low: $118
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-05 | H.C. WainwrightAndrew Fein | $187 | 51.8% upside |  |
| 2025-05-02 | OppenheimerJay Olson | $205 | 66.5% upside | |
| 2025-04-28 | HSBC | $118 |  4.2% downside | |
| 2025-02-13 | Canaccord GenuitySumant Kulkarni | $265 | 115.2% upside | |
| 2025-02-12 | CitigroupGeoff Meacham | $160 | 29.9% upside | |
| 2025-02-12 | Wells FargoMohit Bansal | $165 | 34% upside | |
| 2025-02-12 | NeedhamAmi Fadia | $270 | 119.2% upside | |
| 2024-12-09 | JefferiesMichael Yee | $180 | 46.2% upside | |
| 2024-11-15 | Robert W. BairdBrian Skorney | $300 | 143.6% upside | |
| 2024-10-31 | Morgan StanleyTerence Flynn | $204 | 65.6% upside | |
| 2024-10-31 | OppenheimerJay Olson | $255 | 107% upside | |
| 2024-10-30 | Raymond JamesChristopher Raymond | $315 | 155.8% upside | |
| 2024-10-30 | Goldman SachsSalveen Richter | $290 | 135.5% upside | |
| 2024-10-17 | BMO CapitalEvan Seigerman | $230 | 86.7% upside | |
| 2024-10-03 | UBSAshwani Verma | $202 | 64% upside | |
| 2024-09-23 | WedbushLaura Chico | $205 | 66.5% upside | |
| 2024-07-29 | Robert W. BairdBrian Skorney | $294 | 138.7% upside | |
| 2024-07-26 | Goldman SachsSalveen Richter | $342 | 177.7% upside | |
| 2024-07-26 | Piper SandlerChristopher Raymond | $307 | 149.3% upside | |
| 2024-07-26 | RBC CapitalBrian Abrahams | $282 | 129% upside | |
| 2024-07-12 | Piper SandlerChristopher Raymond | $313 | 154.1% upside | |
| 2024-07-11 | Morgan StanleyTerence Flynn | $311 | 152.5% upside | |
| 2024-06-12 | ScotiabankGeorge Farmer | $275 | 123.3% upside | |
| 2024-05-23 | BMO CapitalEvan David Seigerman | $260 | 111.1% upside | |
| 2024-05-22 | Morgan StanleyMatthew Harrison | $331 | 168.8% upside | |
| 2024-05-22 | Stifel NicolausPaul Matteis | $275 | 123.3% upside | |
| 2024-05-22 | Raymond JamesChristopher Raymond | $335 | 172% upside | |
| 2024-04-25 | H.C. WainwrightAndrew Fein | $300 | 143.6% upside | |
| 2024-04-25 | WedbushLaura Chico | $215 | 74.6% upside | |
| 2024-04-25 | RBC CapitalBrian Abrahams | $317 | 157.4% upside | |
| 2024-04-19 | OppenheimerJay Olson | $270 | 119.2% upside | |
| 2024-04-03 | BarclaysCarter Gould | $215 | 74.6% upside | |
| 2023-08-07 | WedbushLaura Chico | $269 | 118.4% upside | |
| 2023-05-01 | GuggenheimYatin Suneja | $350 | 184.2% upside | |
| 2022-12-01 | Atlantic Equities | $295 | 139.5% upside | |
| 2022-11-30 | Barclays | $313 | 154.1% upside | |
| 2022-11-30 | Jefferies | $350 | 184.2% upside | |
| 2022-11-30 | Wedbush | $247 | 100.6% upside | |
| 2022-11-15 | Truist Financial | $350 | 184.2% upside | |
| 2022-11-11 | Guggenheim | $270 | 119.2% upside | |
| 2022-09-30 | J.P. Morgan | $275 | 123.3% upside | |
| 2022-09-28 | Atlantic EquitiesSteve Chesney | $200 | 62.4% upside | |
| 2022-09-28 | RBC Capital | $321 | 160.6% upside | |
| 2022-09-28 | Morgan StanleyMatthew Harrison | $285 | 131.4% upside | |
| 2022-09-28 | NeedhamAmi Fadia | $250 | 103% upside | |
| 2022-09-28 | Wedbush | $217 | 76.2% upside | |
| 2022-09-28 | Wells Fargo | $350 | 184.2% upside | |
| 2022-09-28 | Piper Sandler | $280 | 127.3% upside | |
| 2022-09-28 | BMO CapitalEvan David Seigerman | $360 | 192.3% upside | |
| 2022-09-28 | Mizuho SecuritiesSalim Syed | $270 | 119.2% upside | |